| Literature DB >> 18625340 |
Valerie G Brunton1, Margaret C Frame.
Abstract
Over the past few years small molecule inhibitors of both Src family kinases and focal adhesion kinase (FAK) have entered clinical studies for the treatment of solid tumours. These adhesion-linked kinases are involved in a number of pathways that have impact on the behaviour of tumour cells and the challenge is now, how to take these forward in the clinical setting.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18625340 DOI： 10.1016/j.coph.2008.06.012
Source DB: PubMed Journal: Curr Opin Pharmacol ISSN： 1471-4892 Impact factor: 5.547